The english version of the website is under development. Wherever text appears in Greek, it means it has not been translated yet.

Publications

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 39 results:
Author Title Type [ Year(Asc)]
Filters: Keyword is Arthritis, Rheumatoid  [Clear All Filters]
2023
Doulberis, M., Papaefthymiou A., Polyzos S. A., Vardaka E., Tzitiridou-Chatzopoulou M., Chatzopoulos D., et al. (2023).  Local and systemic autoimmune manifestations linked to hepatitis A infection.. Acta Gastroenterol Belg. 86(3), 429-436.
2019
Anyfanti, P., Gkaliagkousi E., Gavriilaki E., Triantafyllou A., Dolgyras P., Galanopoulou V., et al. (2019).  Association of galectin-3 with markers of myocardial function, atherosclerosis, and vascular fibrosis in patients with rheumatoid arthritis.. Clin Cardiol. 42(1), 62-68.
Ntusi, N. A. B., Francis J. M., Gumedze F., Karvounis H., Matthews P. M., Wordsworth P. B., et al. (2019).  Cardiovascular magnetic resonance characterization of myocardial and vascular function in rheumatoid arthritis patients.. Hellenic J Cardiol. 60(1), 28-35.
Ntelios, D., Karamitsos T. D., Boufidou A., Thisiadou K., & Karvounis H. (2019).  Inconsistent high sensitivity troponin T and I measurements in a patient with rheumatoid arthritis.. Hellenic J Cardiol. 60(1), 59-60.
Anyfanti, P., Triantafyllou A., Gkaliagkousi E., Zabulis X., Dolgyras P., Galanopoulou V., et al. (2019).  Urinary albumin excretion in rheumatoid arthritis is not associated with markers of vasculopathy in distal microvascular beds.. Microcirculation. 26(1), e12514.
2018
Gkaliagkousi, E., Anyfanti P., Chatzimichailidou S., Triantafyllou A., Lazaridis A., Aslanidis S., et al. (2018).  Association of nocturnal blood pressure patterns with inflammation and central and peripheral estimates of vascular health in rheumatoid arthritis.. J Hum Hypertens. 32(4), 259-267.
Anyfanti, P., Triantafyllou A., Gkaliagkousi E., Koletsos N., Aslanidis S., & Douma S. (2018).  Association of non-invasive hemodynamics with arterial stiffness in rheumatoid arthritis.. Scand Cardiovasc J. 52(4), 171-176.
Anyfanti, P., Gkaliagkousi E., Triantafyllou A., Zabulis X., Dolgyras P., Galanopoulou V., et al. (2018).  Dermal capillary rarefaction as a marker of microvascular damage in patients with rheumatoid arthritis: Association with inflammation and disorders of the macrocirculation.. Microcirculation. 25(5), e12451.
Skalkou, A., Manoli S-M., Sachinidis A., Ntouros V., Petidis K., Pagkopoulou E., et al. (2018).  Pyoderma gangrenosum and pyogenic arthritis presenting as severe sepsis in a rheumatoid arthritis patient treated with golimumab.. Rheumatol Int. 38(1), 161-167.
2017
Dimitroulas, T., Hodson J., Sandoo A., Smith J., & Kitas G. D. (2017).  Endothelial injury in rheumatoid arthritis: a crosstalk between dimethylarginines and systemic inflammation.. Arthritis Res Ther. 19(1), 32.
Dimitroulas, T., Hodson J., Panoulas V. F., Sandoo A., Smith J., & Kitas G. (2017).  Genetic variations in the alanine-glyoxylate aminotransferase 2 (AGXT2) gene and dimethylarginines levels in rheumatoid arthritis.. Amino Acids. 49(6), 1133-1141.
Anyfanti, P., Triantafyllou A., Gkaliagkousi E., Koletsos N., Athanasopoulos G., Zabulis X., et al. (2017).  Retinal vessel morphology in rheumatoid arthritis: Association with systemic inflammation, subclinical atherosclerosis, and cardiovascular risk.. Microcirculation. 24(8), 
Anyfanti, P., Triantafyllou A., Gkaliagkousi E., Triantafyllou G., Koletsos N., Chatzimichailidou S., et al. (2017).  Subendocardial viability ratio in patients with rheumatoid arthritis: comparison with healthy controls and identification of prognostic factors.. Clin Rheumatol. 36(6), 1229-1236.
2015
Sandoo, A., Dimitroulas T., Hodson J., Smith J. P., Douglas K. M., & Kitas G. D. (2015).  Cumulative inflammation associates with asymmetric dimethylarginine in rheumatoid arthritis: a 6 year follow-up study.. Rheumatology (Oxford). 54(7), 1145-52.
2014
Dimitroulas, T., Sandoo A., Smith J. P., & Kitas G. D. (2014).  Asymmetric dimethylarginine is not associated with subendocardial viability ratio in Rheumatoid Arthritis.. Int J Cardiol. 172(1), 285-6.
Metsios, G. S., Stavropoulos-Kalinoglou A., van Zanten J. J. C. S. Veld, Nightingale P., Sandoo A., Dimitroulas T., et al. (2014).  Individualised exercise improves endothelial function in patients with rheumatoid arthritis.. Ann Rheum Dis. 73(4), 748-51.
Chatzikyriakidou, A., Voulgari P. V., & Drosos A. A. (2014).  Lack of association of the autophagy-related gene polymorphism ATG16L1 rs2241880 in RA predisposition.. Rheumatol Int. 34(4), 477-9.
Chatzikyriakidou, A., Voulgari P. V., & Drosos A. A. (2014).  Lack of association of the GSDMB gene at locus 17q12 with predisposition to rheumatoid arthritis.. Clin Exp Rheumatol. 32(3), 447.
Dimitroulas, T., Sandoo A., Hodson J., Smith J., Panoulas V. F., & Kitas G. D. (2014).  Relationship between dimethylarginine dimethylaminohydrolase gene variants and asymmetric dimethylarginine in patients with rheumatoid arthritis.. Atherosclerosis. 237(1), 38-44.
Mavrogeni, S., Dimitroulas T., Bucciarelli-Ducci C., Ardoin S., Sfikakis P. P., Kolovou G., et al. (2014).  Rheumatoid arthritis: an autoimmune disease with female preponderance and cardiovascular risk equivalent to diabetes mellitus: role of cardiovascular magnetic resonance.. Inflamm Allergy Drug Targets. 13(2), 81-93.
Sarantopoulos, A., Tselios K., Gkougkourelas I., Pantoura M., Georgiadou A-M., & Boura P. (2014).  Tocilizumab treatment leads to a rapid and sustained increase in Treg cell levels in rheumatoid arthritis patients: comment on the article by Thiolat et al.. Arthritis Rheumatol. 66(9), 2638.
Mavrogeni, S., Dimitroulas T., Gabriel S., Sfikakis P. P., Pohost G. M., & Kitas G. D. (2014).  Why currently used diagnostic techniques for heart failure in rheumatoid arthritis are not enough: the challenge of cardiovascular magnetic resonance imaging.. Rev Cardiovasc Med. 15(4), 320-31.
2013
Dimitroulas, T., Nikas S. N., Trontzas P., & Kitas G. D. (2013).  Biologic therapies and systemic bone loss in rheumatoid arthritis.. Autoimmun Rev. 12(10), 958-66.
Dimitroulas, T., Douglas K. M. J., Panoulas V. F., Toms T., Smith J. P., Treharne G. J., et al. (2013).  Derangement of hemostasis in rheumatoid arthritis: association with demographic, inflammatory and metabolic factors.. Clin Rheumatol. 32(9), 1357-64.
Gavriilaki, E., Gkaliagkousi E., Nikolaidou B., & Douma S. (2013).  Does vitamin D really contribute to excess cardiovascular risk in rheumatoid arthritis? Comment on the article by Haque et al.. Arthritis Care Res (Hoboken). 65(7), 1203.

Pages

Contact

Secretariat of the School of Medicine
 

Connect

School of Medicine's presence in social networks
Follow Us or Connect with us.